| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/11/2012 | EP2438088A1 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections |
| 04/11/2012 | EP2438087A2 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or the treatment of respiratory tract infections |
| 04/11/2012 | EP2438084A2 Antibodies against human ccn1 and uses thereof |
| 04/11/2012 | EP2437785A2 METHODS FOR IDENTIFICATION OF SITES FOR IgG CONJUGATION |
| 04/11/2012 | EP2437780A1 Therapeutic compositions and methods for the prevention of autoimmune diseases |
| 04/11/2012 | EP2437779A1 Reagents and methods for detecting influenza virus proteins |
| 04/11/2012 | EP2437767A1 Molecules with extended half-lives and uses thereof |
| 04/11/2012 | EP2437727A2 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 04/11/2012 | EP2115470B1 An activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules |
| 04/11/2012 | EP2025749B1 Humanized anti-human osteopontin antibody |
| 04/11/2012 | EP1835937B1 Compositions and methods for treating viral infection |
| 04/11/2012 | EP1763364B1 Methods and compositions comprising supramolecular constructs |
| 04/11/2012 | EP1718767B1 Compositions for treating breast and pancreatic cancer |
| 04/11/2012 | EP1718676B1 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |
| 04/11/2012 | EP1703893B1 Novel anti-il 13 antibodies and uses thereof |
| 04/11/2012 | EP1631316B1 Targeted biocides |
| 04/11/2012 | EP1594533B1 Antibody vaccine conjugates and uses therefor |
| 04/11/2012 | EP1575517B1 Anti-ngf antibodies and methods using same |
| 04/11/2012 | EP1541680B9 Cytotoxic antibody against a c-terminal peptide of gpc3 |
| 04/11/2012 | EP1503794B1 Methods of treatement using ctla-4 antibodies |
| 04/11/2012 | EP1282646B1 Human monoclonal antibodies to dendritic cells |
| 04/11/2012 | EP1125947B1 Human H37 protein and cDNA encoding the same |
| 04/11/2012 | EP0931162B1 Production of a multimeric protein by cell fusion method |
| 04/11/2012 | CN102414223A 对IL12受体β亚基特异的治疗性抗体的组合物和方法 The compositions and methods of the IL12 receptor β subunit-specific therapeutic antibody |
| 04/11/2012 | CN102414222A Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof |
| 04/11/2012 | CN102414221A 抗体配制剂 Antibody formulations |
| 04/11/2012 | CN102414219A 针对人ccn1的抗体及其用途 Antibodies against human ccn1 their uses |
| 04/11/2012 | CN102414218A Tag peptide having protease recognition sequence and utilization of same |
| 04/11/2012 | CN102411051A 有机磷农药多残留的免疫检测方法 Organophosphorus pesticide residues in immunoassay |
| 04/11/2012 | CN102409029A 杂交瘤细胞株3d6及利用其制备抗甘草酸单克隆抗体的方法 3d6 and hybridoma cell lines using the method of preparation of monoclonal antibodies anti Glycyrrhizinate |
| 04/11/2012 | CN102409028A 肠道病毒71型单克隆抗体及其应用 Enterovirus 71 monoclonal antibody and its application |
| 04/11/2012 | CN102409027A 快速检测滴滴涕及其代谢物的酶联免疫试剂盒及其制法 Rapid detection of DDT and its metabolites ELISA kit Jiqizhifa |
| 04/11/2012 | CN102408483A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/11/2012 | CN102408482A 一种β-伴大豆球蛋白单克隆抗体制备方法 One kind of β- conglycinin preparation of monoclonal antibodies |
| 04/11/2012 | CN102406944A 抗ku70内化的抗体 Within the anti-ku70 antibodies |
| 04/11/2012 | CN101277976B 抗肌抑制素抗体 Anti-myostatin antibodies |
| 04/10/2012 | US8153775 Kits for detecting rank |
| 04/10/2012 | US8153774 Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids |
| 04/10/2012 | US8153768 Complex of antibodic and antibiotic with carrier |
| 04/10/2012 | US8153767 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 04/10/2012 | US8153766 Monoclonal antibodies against activated protein C |
| 04/10/2012 | US8153761 Microwave-assisted peptide synthesis |
| 04/10/2012 | US8153759 Depsipeptide containing lactic acid residue |
| 04/10/2012 | US8153593 Transglutaminase inhibitors and methods of use thereof |
| 04/10/2012 | US8153583 Toll like receptor 3 antagonists, methods and uses |
| 04/10/2012 | US8153582 Personal-care articles having self-assembling peptides |
| 04/10/2012 | US8153580 Nogo receptor binding protein |
| 04/10/2012 | US8153422 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases |
| 04/10/2012 | US8153411 Dehalogenases, nucleic acids encoding them and methods for making and using them |
| 04/10/2012 | US8153398 Polynucleotides encoding signal peptide-containing molecules |
| 04/10/2012 | US8153360 Flavivirus fusion inhibitors |
| 04/10/2012 | US8153135 Polysaccharide-polypeptide conjugate |
| 04/10/2012 | US8153134 Anti-MDL-1 antibodies |
| 04/10/2012 | US8153133 High potency recombinant antibodies and method for producing them |
| 04/10/2012 | US8153132 Antibodies immunoreactive with mutant hydroxypenylpyruvate dioxygenase |
| 04/10/2012 | US8153129 Antibodies against human cytimegalovirus (HCMV) |
| 04/10/2012 | US8153128 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 04/10/2012 | US8153126 Anti-αvβ6 antibodies |
| 04/10/2012 | US8153125 CD20 binding molecules |
| 04/10/2012 | US8153124 Method for treating cancer using monoclonal antibodies |
| 04/10/2012 | US8153121 Multiple sclerosis; Crohn's disease |
| 04/10/2012 | US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 04/10/2012 | CA2539846C Hepatitis c virus ns2/3 assay |
| 04/10/2012 | CA2473754C Treatment of ms with goat serum |
| 04/10/2012 | CA2468496C Ilk inhibitors for the treatment of renal disease |
| 04/10/2012 | CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/10/2012 | CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/10/2012 | CA2360511C Methods for generating phosphorylation site-specific immunological reagents |
| 04/10/2012 | CA2352783C Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 04/05/2012 | WO2012045085A1 Anti-rori antibodies |
| 04/05/2012 | WO2012044893A1 Polypeptides that bind to human complement component c5 |
| 04/05/2012 | WO2012043634A1 Antibody against human prostaglandin e2 receptor ep4 |
| 04/05/2012 | WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier |
| 04/05/2012 | WO2012042270A1 Antibody specifically binding synovial microvasculature of arthritis patients |
| 04/05/2012 | WO2012042026A1 Biological materials related to c-met |
| 04/05/2012 | WO2012042009A1 Means and methods for diagnosing cancer using an antibody which specifically binds to braf v600e |
| 04/05/2012 | WO2012041863A1 Compositions and methods for treating neoplasia |
| 04/05/2012 | WO2012041800A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl |
| 04/05/2012 | WO2012041635A1 Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
| 04/05/2012 | WO2012041018A1 ANTI TNF α HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF |
| 04/05/2012 | WO2012040824A1 Anti-ceacam6 antibodies and uses thereof |
| 04/05/2012 | WO2012017328A3 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 04/05/2012 | WO2012009544A3 Domain insertion immunoglobulin |
| 04/05/2012 | WO2012007849A3 Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| 04/05/2012 | WO2011160132A3 Detection of epha3 as a marker of the presence of a solid tumor |
| 04/05/2012 | WO2011159735A3 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 04/05/2012 | WO2011153380A3 Humanized monoclonal antibodies and methods of use |
| 04/05/2012 | WO2011150086A3 Diagnosis and treatment of autoimmune disease |
| 04/05/2012 | WO2011142545A3 Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system |
| 04/05/2012 | WO2011140295A3 Modulators of notch receptor signaling and methods of use thereof |
| 04/05/2012 | WO2011127324A3 Antibodies to cd122 |
| 04/05/2012 | WO2011119979A3 Antibodies to muc16 and methods of use thereof |
| 04/05/2012 | WO2011119915A3 Method for detecting lipogenic adenovirus |
| 04/05/2012 | WO2011116226A3 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 04/05/2012 | WO2011116209A3 Using phage epitopes to profile the immune response |
| 04/05/2012 | WO2011111966A3 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 04/05/2012 | WO2011109789A3 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 04/05/2012 | WO2011007180A9 Immunodetection and quantification of pyrazolopyrimidine sedatives |
| 04/05/2012 | US20120084885 Promoter, promoter control elements, and combinations, and uses thereof |
| 04/05/2012 | US20120084871 Npc1l1 orthologues |